Feramda Biopharmaceutical

Tellurium-based Drugs for Treating Wet Macular Degeneration

Health Tech & Life Sciences
Non Active, Jun 2022 ceased to operate
Seed Kefar Sava, Israel Founded 2017
Website ↗
Last updated 2026-06-18
Total raised
Last: 2018-12
Stage
Seed
Founded
2017
Headcount
2
HQ
Kefar Sava, Israel
Sector
Health Tech & Life Sciences

About

Feramda Biopharmaceutical develops safe tellurium-based oral drugs that are designed to reduce the number of intravitreal anti-vascular endothelial growth factor injections needed in the treatment of wet age-related macular degeneration, a disease that can cause blindness. Tellurium-based molecules inhibit angiogenesis through a unique mechanism of action that increases angiogenesis inhibitors in the eye and inhibits inflammation.

Funding history · 1 round · — total

2018-12
Undisclosed

Q&A

What is Feramda Biopharmaceutical's primary focus?
Feramda Biopharmaceutical develops tellurium-based oral drugs for treating wet age-related macular degeneration, aiming to reduce the need for intravitreal anti-vascular endothelial growth factor injections.
When was Feramda Biopharmaceutical founded?
Feramda Biopharmaceutical was founded in January 2017.
What is the current operational status of Feramda Biopharmaceutical?
Feramda Biopharmaceutical is currently inactive, having ceased operations in June 2022.
How many employees does Feramda Biopharmaceutical have?
Feramda Biopharmaceutical has 1-10 employees.
Which investor participated in Feramda Biopharmaceutical's funding round in December 2018?
ATOORO Fund participated in Feramda Biopharmaceutical's funding round in December 2018.
Who are the co-founders of Feramda Biopharmaceutical?
The co-founders of Feramda Biopharmaceutical are Prof. Benjamin Sredni and Joseph R. Ferencz, M.D.
What is the primary sector of Feramda Biopharmaceutical?
Feramda Biopharmaceutical's primary sector is Health Tech & Life Sciences.

Team · 2

Founder · Co-founder
LinkedIn ↗
Founder · Co-founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

oral-drugsseniorsbiopharmaceuticalpharmaceuticalsophthalmologyeye-diseasesdrug-discovery
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteferamda.com/

Identifiers & details

Founded2017-1
Employees (exact)2
Status reasonNon Active, Jun 2022 ceased to operate